Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
cancer
4
×
life sciences
national blog main
biotech
clinical trials
new york blog main
san francisco blog main
europe blog main
fda
national top stories
new york top stories
san francisco top stories
startups
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
codiak biosciences
community oncology alliance
cutaneous t-cell lymphoma
cvs health
deciphera pharmaceuticals
deerfield management
detroit blog main
What
medicines
4
×
new
4
×
ipo
cancer
activity
aim
approvals
based
begin
bio
biogen
biosciences
biotech
bio’s
black
boost
brings
bubbles
cells
change
clamped
class
clinic
clinical
codiak
community
companies
covid
delays
developing
diagnostics
diamond
docs
drug
economic
eluded
exosome
exosomes
fast
fda
Language
unset
Current search:
medicines
×
cancer
×
" boston blog main "
×
new
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care